We are live on ! Find out more
VCYT icon

Veracyte

55 hedge funds and large institutions have $82.9M invested in Veracyte in 2016 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 18 increasing their positions, 14 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

29% more repeat investments, than reductions

Existing positions increased: 18 | Existing positions reduced: 14

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

14% less funds holding

Funds holding: 6455 (-9)

24% less capital invested

Capital invested by funds: $110M → $82.9M (-$26.8M)

69% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 13

93% less call options, than puts

Call options by funds: $135K | Put options by funds: $1.87M

Holders
55
Holders Change
-9
Holders Change %
-14.06%
% of All Funds
1.46%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
4
Increased
18
Reduced
14
Closed
13
Calls
$135K
Puts
$1.87M
Net Calls
-$1.74M
Net Calls Change
-$1.57M

VCYT Hedge Fund Activity: Q1 2016 in Review

55 of the 3,767 institutional investors tracked by Wall St. Rank reported a position in Veracyte (VCYT) for Q1 2016, worth a combined $82.9M — down 24% from $110M a quarter earlier.

Sellers outnumbered buyers: 13 funds closed out of VCYT and 4 opened new positions — a net loss of 9 holders — while 14 trimmed existing stakes and 18 added.

The largest buyer was Acuta Capital Partners, adding an estimated $6.04M. The largest seller was Driehaus Capital Management, exiting entirely with an estimated $2.03M sold.

  • 55 institutional investors held Veracyte (VCYT) as of Q1 2016, down from 64 in Q4 2015.
  • Funds reported $82.9M of Veracyte stock for Q1 2016, down 24% quarter-over-quarter.
  • 4 funds opened new Veracyte positions in Q1 2016 and 13 closed out, a net change of -9 holders.
  • The largest Veracyte buyer in Q1 2016 was Acuta Capital Partners, an estimated $6.04M added.
  • The largest Veracyte seller in Q1 2016 was Driehaus Capital Management, an estimated $2.03M sold.

Based on aggregated 13F filings for Q1 2016.